Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

71 Results Found

Public

AHA, Health Organizations Express Support for the Preventing Drug Shortages Act

 AHA, health organizations letter to Representatives Peters, Engel, Eshoo, Schrader, Guthrie, Hudson, McCaul, and Bilirakis, supporting the Preventing Drug Shortages Act. 
Public

AHA, Others Urge Senate HELP Committee to Advance MEDS Act (S.2723)

AHA, others urge Senate HELP Committee to advance MEDS Act (S.2723).

FDA issues proposed rule, guidance on importing prescription drugs

The Food and Drug Administration today released a proposed rule that would allow states and other non-federal government entities to establish programs to import certain FDA-approved prescription drug and biological products from Canada.

Health care leaders urge Congress to address shortage of critical drugs

Drug shortages threaten the quality of patient care, narrow treatment options and often result in the use of potentially less effective alternative medications, hospital and health system leaders said at a briefing today on Capitol Hill.
Public

Groups Voice Support for Drug Shortages Bill; FDA Reports on Root Causes

The AHA, American Society of Anesthesiologists, American Society of Clinical Oncology, American Society of

Groups voice support for drug shortages bill; FDA reports on root causes

The AHA, American Society of Anesthesiologists, American Society of Clinical Oncology, American Society of Health-System Pharmacists and Institute for Safe Medication Practices today voiced strong support for the Mitigating Emergency Drug Shortages Act.

FDA: Record number of generic drugs approved in FY 2019

The Food and Drug Administration approved a record high 1,171 generic drugs in fiscal year 2019, the agency said today.

AHA, others comment to DEA on controlled substances quotas

The AHA and six other organizations today submitted comments to the Drug Enforcement Administration on its proposed rule regarding controlled substances quotas.

Civica Rx Delivers First Generic Drug

In what is being hailed as a model for provider-led innovation, Civica Rx, the startup formed last year by a group of health systems to combat rising drug prices and shortages of drugs long on the market, recently made its first delivery of generic medications to a hospital.
Public

AHA Comments on DEA’s Proposed Aggregate Production Quotas for Controlled Substances, Schedule I and II

The AHA appreciates the opportunity to comment on the Drug Enforcement Administration’s proposed notice on aggregate production quotas for schedule I and II controlled substances.